.

More research need­ed on use of ‘smart drugs’ by healthy peo­ple (Med­ical News):

“Drugs such as methylphenidate and modafinil, mar­ket­ed as Rital­in and Provig­il respec­tive­ly, are used by some healthy indi­vid­u­als in order to boost their cog­ni­tive per­for­mance, despite a gen­er­al lack of knowl­edge about Read the rest of this entry »

.

Will 2015 be the year our smart­phones link up to our brains? (Pop­u­lar Sci­ence):

“Thync bills itself first and fore­most as a neu­ro­science com­pa­ny. Its sole product—slated for release lat­er this year—is a smart­phone-con­trolled wear­able device that will allow the user to active­ly alter his or her brain’s elec­tri­cal state through tran­scra­nial direct cur­rent stim­u­la­tion (tDCS). The big idea: Read the rest of this entry »

ADHD med­ica­tion enhances the risk of heart prob­lems in chil­dren (Sci­ence Nordic):

“The risk of devel­op­ing heart prob­lems is twice as big for chil­dren tak­ing med­i­cine for Atten­tion Deficit-Hyper­ac­tiv­i­ty Dis­or­der (ADHD) when com­pared to chil­dren not receiv­ing the medicine…The study builds on data from 714,000 chil­dren Read the rest of this entry »

Rital­in may pose brain risks for young peo­ple with­out ADHD, study shows (Fox News):

“Smart” drugs, like Rital­in, also known as nootrop­ics, are known to increase a person’s atten­tion span, mem­o­ry and abil­i­ty to stay alert. As a result, they have become increas­ing­ly abused by stu­dents seek­ing an extra edge in their stud­ies. Accord­ing to a report from The Part­ner­ship at Drugfree.org and the MetLife Foun­da­tion, approx­i­mate­ly 1.3 mil­lion Amer­i­can teenag­er Read the rest of this entry »

Neu­ro­feed­back — also known as EEG Biofeed­back — is an ADHD treat­ment in which indi­vid­u­als learn to alter their typ­i­cal EEG pat­tern to one that is con­sis­tent with a focused, atten­tive state. This is done by col­lect­ing EEG data from indi­vid­u­als as they focus on stim­uli pre­sent­ed on a com­put­er screen. Their abil­i­ty to Read the rest of this entry »